People

David Palacios
Head Global Patient Advocacy Pharma at Novartis based in Basel
Basel, Switzerland

Sandra Blum
Global Head Patient Advocacy - CardioMetabolic Franchise / Fostering patient engagement and advocacy
Switzerland

Mathieu Boudes
PARADIGM coordinator (http://imi-paradigm.eu/)
Paris, France

Paul Robinson
Assoc. Director, Scientific Medical & Patient Perspective
Philadelphia, United States

Tjerk Jan Schuitmaker
Assistant Professor System Innovations in Health Care
Amsterdam, Netherlands

Sharareh Hosseinzadeh
Global Head Clinical Patient Engagement -Chief Medical Office at Novartis
Dorval, Canada

Nicola Bedlington
Secretary General at European Patients' Forum
Brussels, Belgium

Begoña Nafría Escalera
Patient Expert Reviewer en Research Involvement and Engagement Journal
Esplugues de Llobregat, Spain
Sant Joan de Déu Children's Hospital / Sant Joan de Déu Research Foundation

Harriet Adams
Public Affairs Manager at The Association of the British Pharmaceutical Industry (ABPI)

Sheuli Porkess
Interim Director Research, Medical & Innovation at ABPI; Director Actaros Medical Affairs Consultancy
Organizations
Resources

22 Oct 2020 Framework/guidance

Guidance for Reporting and Dissemination of Patient Engagement Activities
22 Oct 2020 Framework/guidance

Patient engagement in medicines development: Recommendations on how to find the right match for the right patient engagement activity
22 Oct 2020 Framework/guidance

Code of Conduct for all stakeholders involved in patient engagement activities within medicines development
22 Oct 2020 Framework/guidance

Working with Community Advisory Boards: Guidance and tools for patient communities and pharmaceutical companies
10 Sep 2020 Framework/guidance

Raising awareness on managing competing interests in a multi-stakeholder environment: Guidance to patients and engaging stakeholders
10 Sep 2020 Framework/guidance

PEOF 2020 - Patient Engagement Monitoring and Evaluation Framework with metrics
15 Sep 2020 Framework/guidance

18 Oct 2019 Publication